IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,931,996 | -19.8% | 658,935 | -5.6% | 0.06% | -87.3% |
| Q4 2022 | $8,647,130 | +16.9% | 697,912 | -2.2% | 0.50% | +207.5% |
| Q3 2022 | $7,395,000 | -12.9% | 713,805 | -3.1% | 0.16% | -4.2% |
| Q2 2022 | $8,494,000 | -9.7% | 736,648 | -1.5% | 0.17% | +9.1% |
| Q1 2022 | $9,406,000 | -13.6% | 747,687 | -20.0% | 0.15% | -7.2% |
| Q4 2021 | $10,891,000 | -12.7% | 934,055 | -2.2% | 0.17% | -14.4% |
| Q3 2021 | $12,472,000 | -1.7% | 955,008 | -3.1% | 0.19% | +1.6% |
| Q2 2021 | $12,689,000 | +16.1% | 985,905 | +0.9% | 0.19% | +7.9% |
| Q1 2021 | $10,925,000 | – | 977,173 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |